MLXIPL and hepatocellular carcinoma: Altogether, these data demonstrate that alterations in glutamine metabolism and pyrimidine synthesis are consistent across HCC clinical cohorts and strengthen the role of ChREBP in rewiring glutamine metabolism during human liver carcinogenesis (Supplementary Fig. 11e).